UAB MENTAL RETARDATION RESEARCH CENTER (MRRC)

UAB 智力低下研究中心 (MRRC)

基本信息

  • 批准号:
    7330237
  • 负责人:
  • 金额:
    $ 25.25万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2000
  • 资助国家:
    美国
  • 起止时间:
    2000-08-04 至 2008-06-30
  • 项目状态:
    已结题

项目摘要

Developmental disabilities, including mental retardation and other disorders that affect personality, intellectual abilities, social interactions and general cognitive performance affect a large fraction of the population in the United States at some stage of their lives. In addition to these primary disorders of brain function, there are many other disabilities that result from primary disruption of other organ systems including the immune, cardiovascular, respiratory, musculo-skeletal and endocrine systems that may also result in developmental disabilities either through direct actions on those systems and/or through secondary effects on the central nervous system. Taken together, these developmental disabilities account for a substantial health burden in the United States (5-10% of the population at a given stage of life representing up to 25 million people) with similar patterns throughout the world (with even greater portions among developing countries) with affected individuals in the hundreds of millions. In addition to the personal suffering and the emotional impact on individuals and families, the burden of these disorders is staggering in terms of economic impact for provision of continuing health care and support services and contributions to society lost. Over the course of the second half of the twentieth century and into the twenty first century, a number of factors have conspired to increase the urgency of addressing these disabilities including: apparent increases in the frequency of certain disorders (e.g. autism spectrum disorders), the technical advances in medicine that have allowed for the rescue and sustainability of very low birthweight and premature infants, the ability to treat a wide spectrum of disorders associated with developmental disabilities effectively prolonging the lives of people with them, the increasing environmental toxic burden in the nation (and world's) air, water and food supplies, the continuing emergence and re-emergence of infectious diseases, many of which can affect developing fetuses and children, exposure to addictive substances such as nicotine, alcohol and various drugs of abuse, the large fraction of the world's children that survive near or below the poverty level, often without adequate daily nutrition or medical care (including prenatal care for mothers) and the perverse converse situation in affluent societies such as the U.S. with diseases of over abundance and indulgence such as childhood obesity and the large fraction of the nation's children who have either no or inadequate insurance and access to healthcare in the United States (10-20%). It is clear that there is no single solution to the wide range of problems confronting the nation (and world) for dealing with this challenge, particularly since there are several hundred known developmental disorders and even more causes ranging from genetic to environmental to infectious to nutritional to psycho-social to economic to educational and that a consilience of ideas, strategies and cross-discipline research and policy initiatives are required to attack most any one. However, there are a number of programs attempting to accomplish exactly that and the nation's Mental Retardation Developmental Disabilities Research Centers (MRRCs or MRDDRCs) represent a major program that promotes cross- and multi-disciplinary research at a number of sites around the country to provide scientifically based answers to the questions of causes, mechanisms, treatments and ultimately cures for many of these disorders. These MRRCs were early into the game of providing environments for collaborative research that cuts across scientific disciplines including the biological, chemical, medical, behavioral, economic, informational, educational, and sociological research - 40 years ahead of the much heralded "roadmap" plan of the NIH in the twenty first century for developing discipline-crossing team approaches to biomedical and behavioral research. The MRRCs provided a structure within academic settings where traditional departmental-based boundaries and rules for tracking credit for scholarly productivity and financial support for the research enterprise often hindered the kind of truly collaborative research that could address the entire range of problems associated with MRDDs. In addition to providing scientific resources in the way of shared core facilities, these Centers also provide an intellectual environment for bringing investigators together from a wide range of disciplines to share their work, listen to the work of others in disparate fields and plan novel and multi-level approaches to vexing questions that often impact multiple systems ranging across levels from molecular to cellular to organ systems to whole person to behavioral and societal. This approach is a signature strength of the entire MRRC program nationwide and a model that newer Centers have expanded upon and that universities and federal agencies have used as a model (although not always acknowledged as such) for modern interdisciplinary research programs. At UAB, there is a rich tradition of this type of interdisciplinary research center. Indeed, since its inception as an independent University in the early 1960s (paralleling the time of the establishment of the MRRCs by the Kennedy Administration), UAB has developed as an institution with a focus on interdisciplinary research where Centers play a major role. Currently, there are 20 University Wide Interdisciplinary. Research Centers (UWIRCs) at UAB that receive over $5M in annual internal funding support from the University (in addition to their extramural support), with several having substantial federal funding and successful track records over many years (e.g. the Comprehensive Cancer Center; the Center for Outcomes Research; the Center for AIDS Research; the Center for Aging; the Center for Biodefense and Emerging Infections, etc.). Thus, when the University won the competitive award (see History below) from Civitan International in 1989 to develop an interdisciplinary research center to focus on developmental disabilities including mental retardation, it was a natural extension of the University' well established culture. Moreover, UAB's history of pediatrics research and clinical service with highly recognized programs in infectious disease, obstetrics and gynecology, the Sparks Clinics for treating children with multiple disabilities and a large range of cognitive disorders and the Developmental Psychology program on intellectual development were a naturally accepting environment for the new CIRC.
发育障碍,包括智力迟钝和其他影响人格、智力的障碍

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Alan Kenneth Percy其他文献

Alan Kenneth Percy的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Alan Kenneth Percy', 18)}}的其他基金

Rett Syndrome (RTT)
雷特综合症 (RTT)
  • 批准号:
    8381940
  • 财政年份:
    2012
  • 资助金额:
    $ 25.25万
  • 项目类别:
Angelman Syndrome (AS)
天使综合症 (AS)
  • 批准号:
    8381938
  • 财政年份:
    2012
  • 资助金额:
    $ 25.25万
  • 项目类别:
Training and Career Development Component
培训和职业发展部分
  • 批准号:
    8330863
  • 财政年份:
    2011
  • 资助金额:
    $ 25.25万
  • 项目类别:
RDCRC Administrative Unit
RDCRC行政单位
  • 批准号:
    8330864
  • 财政年份:
    2011
  • 资助金额:
    $ 25.25万
  • 项目类别:
Angelman Syndrome (AS)
天使综合症(AS)
  • 批准号:
    8142866
  • 财政年份:
    2010
  • 资助金额:
    $ 25.25万
  • 项目类别:
Rett Syndrome (RTT)
雷特综合症 (RTT)
  • 批准号:
    8142867
  • 财政年份:
    2010
  • 资助金额:
    $ 25.25万
  • 项目类别:
Training and Career Development Component
培训和职业发展部分
  • 批准号:
    8142870
  • 财政年份:
    2010
  • 资助金额:
    $ 25.25万
  • 项目类别:
RDCRC Administrative Unit
RDCRC行政单位
  • 批准号:
    8142871
  • 财政年份:
    2010
  • 资助金额:
    $ 25.25万
  • 项目类别:
RDCRC Administrative Unit
RDCRC行政单位
  • 批准号:
    7877174
  • 财政年份:
    2009
  • 资助金额:
    $ 25.25万
  • 项目类别:
Rett syndrome, MECP2 Duplications, and Rett-related Disorders Natural History
Rett 综合征、MECP2 重复和 Rett 相关疾病自然史
  • 批准号:
    9135149
  • 财政年份:
    2009
  • 资助金额:
    $ 25.25万
  • 项目类别:

相似海外基金

RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
获得性免疫缺陷综合症分类的研究支持服务
  • 批准号:
    10219039
  • 财政年份:
    2020
  • 资助金额:
    $ 25.25万
  • 项目类别:
RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
获得性免疫缺陷综合症分类的研究支持服务
  • 批准号:
    9981476
  • 财政年份:
    2019
  • 资助金额:
    $ 25.25万
  • 项目类别:
IGF::OT::IGF RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
IGF::OT::IGF 针对获得性免疫缺陷综合症分类的研究支持服务
  • 批准号:
    9364184
  • 财政年份:
    2016
  • 资助金额:
    $ 25.25万
  • 项目类别:
Human Immunodeficiency Virus (HIV) and Acquired Immunodeficiency Syndrome (AIDS) in Saskatchewan- Where are we now and what does the future hold?
萨斯喀彻温省的人类免疫缺陷病毒(HIV)和获得性免疫缺陷综合症(艾滋病)——我们现在在哪里以及未来会怎样?
  • 批准号:
    236932
  • 财政年份:
    2011
  • 资助金额:
    $ 25.25万
  • 项目类别:
    Miscellaneous Programs
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW COMMI
获得性免疫缺陷综合症研究审查委员会
  • 批准号:
    3554155
  • 财政年份:
    1991
  • 资助金额:
    $ 25.25万
  • 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME REVIEW
获得性免疫缺陷综合症审查
  • 批准号:
    6766860
  • 财政年份:
    1991
  • 资助金额:
    $ 25.25万
  • 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW COMMI
获得性免疫缺陷综合症研究审查委员会
  • 批准号:
    3554156
  • 财政年份:
    1991
  • 资助金额:
    $ 25.25万
  • 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME REVIEW
获得性免疫缺陷综合症审查
  • 批准号:
    6256640
  • 财政年份:
    1991
  • 资助金额:
    $ 25.25万
  • 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW
获得性免疫缺陷综合症研究综述
  • 批准号:
    2063342
  • 财政年份:
    1991
  • 资助金额:
    $ 25.25万
  • 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME REVIEW
获得性免疫缺陷综合症审查
  • 批准号:
    6091256
  • 财政年份:
    1991
  • 资助金额:
    $ 25.25万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了